Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Nandi J. Reddy"'
Autor:
Kelsey S. Lau-Min, Lisa A. Varughese, Maria N. Nelson, Christine Cambareri, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum, Sony Tuteja
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Pharmacogenetic (PGx) testing for germline variants in the DPYD and UGT1A1 genes can be used to guide fluoropyrimidine and irinotecan dosing, respectively. Despite the known association between PGx variants and chemotherapy toxici
Externí odkaz:
https://doaj.org/article/8056029013234379a4bfba137431d963
Autor:
Lisa A. Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, Shannon Terek, Margaret Harr, Hakon Hakonarson, Christine Cambareri, Jessica Marini, Jeffrey Landgraf, Jinbo Chen, Genevieve Kanter, Kelsey S. Lau-Min, Ryan C. Massa, Nevena Damjanov, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum, Sony Tuteja
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundFluoropyrimidines (fluorouracil [5-FU], capecitabine) and irinotecan are commonly prescribed chemotherapy agents for gastrointestinal (GI) malignancies. Pharmacogenetic (PGx) testing for germline DPYD and UGT1A1 variants associated with red
Externí odkaz:
https://doaj.org/article/9516907262044f3197382352e2d55e3c
Autor:
Christine Cambareri, Kelsey S. Lau-Min, Nevena Damjanov, Nandi J. Reddy, Ursina R. Teitelbaum, Sony Tuteja, Randall A. Oyer, Lisa A. Varughese, Ryan Massa
Publikováno v:
Pharmacotherapy
Gastrointestinal (GI) malignancies are among the most commonly diagnosed cancers worldwide. Despite the introduction of targeted and immunotherapy agents in the treatment landscape, cytotoxic agents, such as fluoropyrimidines and irinotecan, remain a
Autor:
Nevena Damjanov, Lisa A. Varughese, Kelsey S. Lau-Min, Ursina R. Teitelbaum, Ryan Massa, Nandi J. Reddy, Sony Tuteja, AnnaClaire Osei-Akoto
Publikováno v:
Journal of Clinical and Translational Science. 5:103-104
IMPACT: The implementation of DPYD and UGT1A1 pharmacogenetic testing, a promising tool of precision medicine, translates evidence-based research into clinical oncology practice with personalized dosing to better predict interpatient variability in c
Autor:
Christine Cambareri, Kelsey S. Lau-Min, Maria N. Nelson, Sony Tuteja, Ursina R. Teitelbaum, Lisa A. Varughese, Nandi J. Reddy, Randall A. Oyer
Publikováno v:
Journal of Clinical Oncology. 39:54-54
54 Background: Pharmacogenetic (PGx) testing for germline variants in the DPYD and UGT1A1 genes can be used to guide fluoropyrimidine and irinotecan dosing, respectively. Despite the known association between PGx variants and chemotherapy toxicity, p
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 48(10)
Ethylene glycol, diethylene glycol and methanol are widely available chemicals and are found in a variety of common household products including antifreeze, windshield washer fluid, brake fluid and lubricants. Following ingestion of these glycols and
Autor:
Nancy L. Lewis, Kristen J. Pierce, Roger B. Cohen, Joseph Paul Eder, Lionel D. Lewis, Feng Guo, Anthony J. Olszanski, Nandi J. Reddy
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(31)
Purpose This phase I, first-in-human study evaluated the safety, tolerability, pharmacokinetics, and maximum-tolerated dose (MTD) of an oral platelet-derived growth factor receptor inhibitor, CP-868,596. Patients and Methods Patients with advanced so
Autor:
Darrell R. Abernethy, Viola Andresen, Arthur J. Atkinson, Michel Azizi, Helen L. Baron, Carol L. Beck, Atta Behfar, Rodney Bell, Eduardo E. Benarroch, Neal L. Benowitz, Wade Berrettini, Joseph S. Bertino, Alfredo Bianchi, Michael J. Blake, Ann F. Bolger, Glenn D. Braunstein, David Brock, Peter A. Calabresi, Michael Camilleri, Mark Chaballa, Omer Chaudhry, Doo-Sup Choi, Bart L. Clarke, Mary E. Dankert, Dawood Darbar, Mark Davis, Daniel Deck, Jan de Gans, Joseph A. DeSimone, Robert B. Diasio, André Diedrich, Darin D. Dougherty, Laurence J. Egan, Claudine El-Beyrouty, Jean-Luc Elghozi, Arthur M. Feldman, Joanne Filicko-O'Hara, Charles W. Flexner, Neal Flomenberg, Joseph F. Foss, Adam M. Frank, Mark A. Frye, Kishor Gandhi, Joseph Genebriera, William R. Gilliland, Jean Gray, Benjamin M. Greenberg, Naomi Gronich, Dolores Grosso, Andrew R. Haas, Wael N. Haidar, Christine A. Haller, Daniel K. Hall-Flavin, Lisa Hamaker, William F. Harvey, James W. Heitz, Steven K. Herrine, Raymond J. Hohl, Sarah A. Holstein, Dorothy Holt, Linda S. Hostelley, Eric R. Houpt, Shiew-Mei Huang, David J. Hunter, Serge Jabbour, Robert M. Jacobson, Arshad Jahangir, Michael A. Jenike, Kristine E. Johnson, Victor M. Karpyak, Gregory L. Kearns, Richard M. Keating, Michael P. Keith, Sundeep Khosla, Julia Kirchheiner, Walter J. Koch, Bruce C. Kone, Walter K. Kraft, Robert F. Kushner, Christine Laine, Richard L. Lalonde, Kiwon Lee, Teofilo Lee-Chiong, Frank T. Leone, Lawrence J. Lesko, Barbara A. Levey, Lionel D. Lewis, Joseph Loscalzo, Anastasios Lymperopoulos, Joseph P. Lynch, Christian Maaser, Viqar Maria, Paul E. Marik, Marco A. Maurtua, Steven E. McKenzie, Alex Mejia, Michael C. Milone, Scott Mintzer, Thomas P. Moyer, David A. Mrazek, Matthew S. Murphy, Filip Mussen, Jasmine Nabi, Victor J. Navarro, Timothy J. Nelson, Dionissios Neofytos, Kathleen A. Neville, Myaing Nyunt, Timothy O'Brien, Inna G. Ovsyannikova, Chi-Un Pae, James F. Pagel, Ashwin A. Patkar, Kah Whye Peng, Edith A. Perez, Ronald C. Petersen, Paul A. Pham, Jennifer M. Phillips, Carissa Pineda, Mark R. Pittelkow, Pierre-François Plouin, Christopher V. Plowe, Gregory A. Poland, Azad Raiesdana, John N. Ratchford, Nandi J. Reddy, Michael D. Reed, Douglas J. Rhee, Robert A. Rizza, David Robertson, Dan M. Roden, Anne M. Rompalo, Simona Rossi, Vivek Roy, Stephen J. Russell, Steven Ryder, Muhammad Wasif Saif, Rajiv Saini, Kyoko Sato, Kathryn M. Schak, Matthias Schwab, Kumar Sharma, Robert G. Sharrar, Leslie M. Shaw, Ludy Shih, Steven J. Siegel, Peter A. Singer, David R. Staskin, Dale W. Stovall, Jerome F. Strauss, Paul V. Targonski, Daniel Tarsy, William S. Tasman, Robert Temple, Andre Terzic, John E. Tetzlaff, Pritish K. Tosh, Erev E. Tubb, Kathleen Uhl, Patrick Vallance, Diederik van de Beek, Adrian Vella, Eugene R. Viscusi, John L. Wagner, Scott A. Waldman, Philip B. Wedegaertner, Alan J. Wein, Ethan Weiner, Richard Weinshilboum, Martijn Weisfelt, Lisa G. Winston, Run Yu, Ying Zhang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59aa74d9c21b3e9f57929352a71a399b
https://doi.org/10.1016/b978-1-4160-3291-5.50001-9
https://doi.org/10.1016/b978-1-4160-3291-5.50001-9
Autor:
Nandi J. Reddy, Lionel D. Lewis
Publikováno v:
Pharmacology and Therapeutics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ab7d5d7e0141f080a03b090c76fbca4
https://doi.org/10.1016/b978-1-4160-3291-5.50066-4
https://doi.org/10.1016/b978-1-4160-3291-5.50066-4
Publikováno v:
Journal of Clinical Oncology. 27:e43-e43